Rituximab (R) In Combination With Interferon-A2a (Ifn) Versus Single R In Patients With Follicular Or Other Cd20+Low-Grade (Indolent) Lymphoma. Final Results From A Randomized Phase Iii Study From The Nordic Lymphoma Group
BLOOD（2012）
关键词
hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要